Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 exon 8 insertion/deletion polymorphism

Nephrology Dialysis Transplantation

Volumn 22, Issue 1, 2007, Pages 196-202

  Wang, Xin ^a,b   Axelsson, Jonas ^a   Nordfors, Louise ^a   Qureshi, A Rashid ^a   Avesani, Carla ^a   Barany, Peter ^a   Schalling, Martin ^a   Heimbürger, Olof ^a   Lindholm, Bengt ^a   Stenvinkel, Peter ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b PEKING UNIVERSITY   (China)

Author keywords

Body composition; Dialysis; Fat mass; Polymorphism; UCP2

Indexed keywords

UNCOUPLING PROTEIN;

ADULT; AGE; AGED; ARTICLE; BODY COMPOSITION; BODY MASS; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; EXON; FEMALE; FOLLOW UP; GENE DELETION; GENE INSERTION; GENOTYPE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LINEAR REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OBESITY; PERITONEAL DIALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM;

ADIPOSE TISSUE; ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; EXONS; FEMALE; HUMANS; ION CHANNELS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; POLYMORPHISM, GENETIC; RENAL DIALYSIS;

EID: 33845994031     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl504     Document Type: Article

References (32)

1. Stenvinkel P, Lindholm B, Lönnqvist F et al. Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 2000; 11: 1303-1309
2. Fernström A, Hylander B, Moritz A et al. Increase of intra-abdominal fat in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1998; 18: 166-171
3. Soreide R, Dracup B, Svarstad E et al. Increased total body fat during PD treatment. Adv Perit Dial 1992; 8: 173-176
4. Kalantar-Zadeh K, Abbott KC, Salahudeen AK et al. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005; 81: 543-554
5. Abbott KC, Glanton CW, Trespalacios FC et al. Body mass index, dialysis modality, and survival: Analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Kidney Int 2004; 65: 597-605
6. Johnson DW, Herzig KA, Purdie DM et al. Is obesity a favorable prognostic factor in peritoneal dialysis patients? Perit Dial Int 2000; 20: 715-721
7. Aslam N, Bernardini J, Fried L et al. Large body mass index does not predict short-term survival in peritoneal dialysis patients. Perit Dial Int 2002; 22: 191-196
8. Beddhu S, Pappas LM, Ramkumar N et al. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 2003; 14: 2366-2372
9. Axelsson J, Heimbürger O, Lindholm B et al. Adipose tissue and its relation to inflammation: The role of adipokines. J Ren Nutr 2005; 15: 131-136
10. Nagy TR, Blaylock ML, Garvey WT. Role of UCP2 and UCP3 in nutrition and obesity. Nutrition 2004; 20: 139-144
11. Walder K, Norman RA, Hanson RL et al. Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima indians. Hum Mol Genet 1998; 7: 1431-1435
12. Nordfors L, Heimbürger O, Lönnqvist F et al. Fat tissue accumulation during peritoneal dialysis is associated with a polymorphism in uncoupling protein 2. Kidney Int 2000; 57: 1713-1719
13. Stenvinkel P, Heimbürger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 2000; 55: 1899-1911
14. Stuart JA, Cadenas S, Jekabsons MB et al. Mitochondrial proton leak and the uncoupling protein 1 homologues. Biochim Biophys Acta 2001; 1504: 144-158
15. Barbe P, Millet L, Larrouy D et al. Uncoupling protein-2 messenger ribonucleic acid expression during very-low-calorie diet in obese premenopausal women. J Clin Endocrinol Metab 1998; 83: 2450-2453
16. Samec S, Seydoux J, Dulloo AG. Role of UCP homologues in skeletal muscles and brown adipose tissue: Mediators of thermogenesis or regulators of lipids as fuel substrate? Faseb J 1998; 12: 715-724
17. Samec S, Seydoux J, Dulloo AG. Interorgan signaling between adipose tissue metabolism and skeletal muscle uncoupling protein homologs: Is there a role for circulating free fatty acids? Diabetes 1998; 47: 1693-1698
18. Roduit R, Morin J, Masse F et al. Glucose down-regulates the expression of the peroxisome proliferator-activated receptor-alpha gene in the pancreatic beta-cell. J Biol Chem 2000; 275: 35799-35806
19. Li LX, Skorpen F, Egeberg K et al. Induction of uncoupling protein 2 mRNA in beta cells is stimulated by oxidation of fatty acids but not by nutrient oversupply. Endocrinology 2002; 143: 1371-1377
20. Patane G, Anello M, Piro S et al. Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-gamma inhibition. Diabetes 2002; 51: 2749-2756
21. Brown JE, Thomas S, Digby JE et al. Glucose induces and leptin decreases expression of uncoupling protein-2 mRNA in human islets. FEBS Lett 2002; 513: 189-192
22. Samec S, Seydoux J, Dulloo AG. Post-starvation gene expression of skeletal muscle uncoupling protein 2 and uncoupling protein 3 in response to dietary fat levels and fatty acid composition: A link with insulin resistance. Diabetes 1999; 48436-441
23. Schrauwen P, Hoppeler H, Billeter R et al. Fiber type dependent upregulation of human skeletal muscle UCP2 and UCP3 mRNA expression by high-fat diet. Int J Obes Relat Metab Disord 2001; 25: 449-456
24. Le Fur S, Le Stunff C, Dos Santos C et al. The common -866 G/A polymorphism in the promoter of uncoupling protein 2 is associated with increased carbohydrate and decreased lipid oxidation in juvenile obesity. Diabetes 2004; 53: 235-239
25. Rousset S, Alves-Guerra MC, Mozo J et al. The biology of mitochondrial uncoupling proteins. Diabetes 2004; 53 [Suppl 1]: S130-135
26. Kopecky J, Rossmeisl M, Flachs P et al. Energy metabolism of adipose tissue - physiological aspects and target in obesity treatment. Physiol Res 2004; 53 [Suppl 1]: S225-232
27. Nawrocki AR, Scherer PE. The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation. Curr Opin Pharmacol 2004; 4: 281-289
28. Bergström J, Lindholm B. Malnutrition, cardiac disease and mortality - An integrated point of view. Am J Kidney Dis 1998; 32: 834-841
29. Roubenoff R. Catabolism of aging: Is it an inflammatory process? Curr Opin Clin Nutr Metab Care 2003; 6: 295-299
30. Kalantar-Zadeh K, Block G, McAllister CJ et al. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 2004; 80: 299-307
31. Axelsson J, Qureshi AR, Suliman ME et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 2004; 80: 1222-1229
32. Stenvinkel P, Ketteler M, Johnson RJ et al. IL-10, IL-6, and TNF-alpha: Central factors in the altered cytokine network of uremia-The good, the bad, and the ugly. Kidney Int 2005; 67: 1216-1233